Prevention of cognitive decline in subjective cognitive decline APOE-ϵ4 carriers after Epigallocatechin gallate and a multimodal intervention, the PENSA study: 1-year follow-up results of the randomized controlled trial

Authors
Category Primary study
ConferenceAlzheimer's Association International Conference, AAIC 2023
Year 2023
This article has no abstract
Epistemonikos ID: 1caf9849169ad040a65dfb216452045fddb6e71b
First added on: Oct 18, 2025